BD MAX™ CT/GC/TV
Elevate the standard of care for STIs
The consequences of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and Trichomonas vaginalis (TV) can be serious. Significant adverse reproductive health outcomes, including pregnancy complications, pelvic inflammatory disease and an increased risk of HIV acquisition, have been linked to TV infection. TV is the most common curable sexually transmitted infection (STI) worldwide. Annually in the United States, millions of new infections are estimated to occur–an amount greater than combined new cases of CT, GC and syphilis.1
Introducing BD MAX™ CT/GC/TV
BD MAX CT/GC/TV is designed to detect the 3 most prevalent non-viral sexually transmitted infections—CT, GC and TV—in a single assay. With BD MAX CT/GC/TV you can provide quality patient care and support clinical decision accuracy and patient management.
- Download the BD MAX™ CT/GC/TV Info Sheet >>
- Download the BD MAX™ CT/GC/TV Specimen Self-Collection Collection Chart
- Download the BD MAX™ CT/GC/TV Specimen Collection and Transfer Procedure Collection Chart
- Watch the BD MAX™ CT/GC/TV Vaginal Specimen Self-Collection Video
- Watch the BD MAX™ CT/GC/TV Endocervical Collection and Transfer Procedure Video
- Read how advances in efficiency of testing such as those delivered by BD MAX™ CT/GC/TV may improve the diagnostic coverage of clinically prevalent STIs, which may lead to enhanced patient management. White Paper >>
- Browse the Resource Center to access scientific publications and more
Visit BD Molecular Diagnostics for detailed information on BD MAX CT/GC/TV (Cat No. 442970).
Reference
- Coleman JS et al. Obstet Gynecol Surv. 2013;68:43-50.
- Centers for Disease Control and Prevention. http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf. Accessed September 19, 2016.
